Skip to main content
Clinical Trials/NCT05739201
NCT05739201RecruitingNot Applicable

Comparative Study Between Interscalene Nerve Block, Anterior Suprascapular Nerve Block, and Pericapsular Nerve Group Block for Arthroscopic Shoulder Surgery

Tanta University1 site in 1 country90 target enrollmentStarted: February 20, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
90
Locations
1
Primary Endpoint
the total opioid consumption.

Study Overview

Brief Summary

This study is designed to investigate the post-operative analgesic effect of interscalene nerve block or anterior suprascapular nerve block compared to pericapsular nerve group block in patient undergoing elective arthroscopic shoulder surgery.

Detailed Description

Shoulder arthroscopy is a common outpatient operation with an increasing number of indications and complexity. Early postoperative pain immediately following shoulder surgery is a major concern and cause of distress for patients and orthopedic surgeons. Adequate pain control is vital for all aspects of the patient's recovery.

Nowadays, several ultrasound -guided regional anesthesia methods are used for postoperative analgesia. Regional techniques such as interscalene and supraclavicular blocks are usually preferred for shoulder analgesia. Interscalene brachial plexus block (ISB) is the gold standard technique in this area.

Suprascapular nerve block (SSB) has been proposed as an alternative to the ISB in providing analgesia for shoulder surgeries as it has a lower likelihood of causing phrenic nerve blockade.

The pericapsular nerve group (PENG) block has been suggested to be safely applied for analgesia and can be part of surgical anesthesia, but alone is not sufficient for anesthesia in shoulder surgery. The block of this area did not cause motor block or pulmonary complications, nor result in muscle laxity, blocking only the shoulder and the upper third of the humerus.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients.
  • •ASA class I and II and scheduled for elective shoulder arthroscopy.

Exclusion Criteria

  • •Patient who refuses the regional anesthesia technique.
  • •History of allergy to local anesthetics.
  • •Local infection at the site of the block.
  • •History of Pre-existing major organ dysfunction such as hepatic and renal failure.
  • •History of pre-existing lung disease (COPD, uncontrolled asthma).
  • •Preexisting upper extremity neurological abnormality or neuropathy.
  • •Difficulties in comprehending (NRS).
  • •Chronic opioid users (opioid intake more than 3 months).

Arms & Interventions

Group (I)

Active Comparator

30 patients will receive interscalene nerve block.

Intervention: interscalene nerve block (Procedure)

Group (II)

Active Comparator

30 Patients will receive anterior suprascapular nerve block.

Intervention: anterior suprascapular nerve block (Procedure)

Group (III)

Active Comparator

30 atients will receive pericapsular nerve group block around shoulder surgery

Intervention: Peri-capsular nerve group block (Procedure)

Outcomes

Primary Outcomes

the total opioid consumption.

Time Frame: 24-hour postoperatively

Postoperative analgesia will be assessed by total opioid consumption and time till administration of first rescue analgesia will be recorded.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shrouk Elsawaf

Resident

Tanta University

Study Sites (1)

Loading locations...

Similar Trials

ISB, SSNB, and PENG Block for Arthroscopic... | Clinical Trial